An analysis, from the cardiology viewpoint, of the MI nomenclature issues around the external validity of the EXCEL trial that undermined the EACTS support of the relevant 2018 guidelines
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization
October 12, 2020
October 4, 2020
The authors are concerned about the 'deaths at home' having the greatest contribution to the excess of acute cardiovascular deaths in that period of the recent epidemic, AND LOCKDOWN in England and Wales.
October 1, 2020
Death from cardiovascular causes, stroke, or hospitalization with worsening of heart failure or acute coronary syndrome was reduced (P=0.005) by early pharmacogical or inteventional ablation for fast response-atrial fibrillation in a small German RCT.
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
September 15, 2020
An open-access large metanalysis on the utility and risks of antiplatelets after PCI. Of note, mortality was not a primary endpoint. The message is that long dual antiplatelet use is an exchange between avoidance of myocardial events and serious bleeding. The novel oral anticoagulants may enter the arena soon..
September 14, 2020
The authors present a 57-year-old woman with a left anterior descending to pulmonary artery fistula, causing progressive and daily ischemic chest pain associated with dyspnea and dizziness.
Is Myocardial Revascularization Really Necessary in Patients With ≥50% but <70% Coronary Stenosis Undergoing Valvular Surgery?
September 11, 2020
Del Forno et al. present a retrospective study of 77 patients with de-novo 50-70% coronary stenosis undergoing valvular surgery. In these patients, bypass grafting of these coronaries was intentionally omitted.
September 10, 2020
Filmed at the 2020 STS Annual Meeting in New Orleans, Louisiana, Niv Ad moderates a discussion on the importance of atrial fibrillation in decision-making in structural heart disease and coronary artery disease.
August 18, 2020
A review that may affect pharma strategy in the immediate future.
August 11, 2020
This is a video illustrating a case of minimally invasive mitral valve replacement in the setting of profound shock with VA-ECMO and impella CP support for ruptured papillary muscle after acute myocardial infarction.
Aortic Root Remodelling, Debranching of Arch, Ascending Aorta Replacement (Lupiae) and CABGX3 Prior TEVAR for Type B Aortic Dissection
August 5, 2020
The authors demonstrate a technique to manage the complex aortic pathology with coronary artery disease following percutaneous thoracic endovascular arterial repair in Ishimaru's zone 2, 3, and 4 in a complicated type B aortic dissection.